Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07213843 · ClinicalTrials.gov registry record · NA
Combined Circulatory and Dietary Interventions for Neuropathy
A NA study, sponsored by Loma Linda University.
- Not yet
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT07213843 is a NA study that has not yet begun recruiting, run by Loma Linda University. The registered enrollment target is 60 participants.
The verdict
NCT07213843, a NA study, has not yet begun recruiting, sponsored by Loma Linda University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effectiveness of three different interventions in improving neuropathy symptoms in individuals aged 35-85 with moderate to severe neuropathy. The study will compare three treatment groups: Intraneural Facilitation® (INF®) therapy alone, INF® therapy combined with Neuro vascular index (NVI) food-guided elimination (NVIf), and NVIf alone. The aim is to determine which treatment results in the greatest improvement in neuropathy symptoms, including quality of life, sensory and pain improvements, and functional outcomes.
Interventions
- OTHER INF® Therapy
- OTHER NVIf
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2026-10-01 |
| Est. Completion | 2028-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07213843
The ClinicalTrials.gov registry entry for NCT07213843 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Loma Linda University, which has 237 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which INF® Therapy is the first listed.
NCT07213843 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07213843 about?
NCT07213843 is a clinical study titled "Combined Circulatory and Dietary Interventions for Neuropathy". The purpose of this study is to evaluate the effectiveness of three different interventions in improving neuropathy symptoms in individuals aged 35-85 with moderate to severe neuropathy. The study will compare three treatment groups: Intraneural Facilitation® (INF®) therapy alone, INF® therapy combi...
What is the current status of trial NCT07213843?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2026-10-01. Estimated completion is 2028-12-01.
What interventions are being tested in trial NCT07213843?
The interventions under investigation include: INF® Therapy (OTHER), NVIf (OTHER).
Who is sponsoring clinical trial NCT07213843?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.